» Articles » PMID: 29021466

Successful Treatment of a Case of Late-onset Colitis After Umbilical Cord Transplantation with Metronidazole: A Case Report and Literature Review

Overview
Journal Intern Med
Specialty General Medicine
Date 2017 Oct 13
PMID 29021466
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Diarrhea after hematopoietic stem cell transplantation (HSCT) can be life-threatening, and its etiology includes conditioning regimens, graft-versus-host disease (GVHD), infections, and transplantation-associated microangiopathy (iTAM). Cord colitis syndrome (CCS) has been described as a syndrome of culture-negative and antibiotic-responsive persistent watery and non-bloody diarrhea of uncertain pathogenesis and occurs in umbilical cord blood transplantation (UCBT) recipients. We encountered a case similar to CCS that developed severe watery diarrhea after UCBT without any signs of GVHD or infection and responded well to metronidazole (MNZ) treatment. Since CCS is very rare, we herein describe a case of MNZ-effective diarrhea after UCBT.

Citing Articles

Metronidazole-induced encephalopathy during treatment for refractory diarrhea after cord blood transplantation.

Iemura T, Kitano T, Ishii A, Hishizawa M, Kondo T, Yamashita K Clin J Gastroenterol. 2019; 12(5):414-419.

PMID: 30835083 DOI: 10.1007/s12328-019-00959-x.

References
1.
Bhatt A, Freeman S, Herrera A, Pedamallu C, Gevers D, Duke F . Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome. N Engl J Med. 2013; 369(6):517-28. PMC: 3889161. DOI: 10.1056/NEJMoa1211115. View

2.
Wick E, Sears C . Bacteroides spp. and diarrhea. Curr Opin Infect Dis. 2010; 23(5):470-4. PMC: 3079340. DOI: 10.1097/QCO.0b013e32833da1eb. View

3.
Magenau J, Reddy P . The difficulty in diagnosing cord colitis. Biol Blood Marrow Transplant. 2014; 20(7):906-7. DOI: 10.1016/j.bbmt.2014.05.006. View

4.
Alsultan A, Giller R, Gao D, Bathurst J, Hild E, Gore L . GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome. Bone Marrow Transplant. 2010; 46(5):668-75. DOI: 10.1038/bmt.2010.174. View

5.
Kenderian S, Porter D, Gill S . Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the Horse. Biol Blood Marrow Transplant. 2016; 23(2):235-246. PMC: 5237606. DOI: 10.1016/j.bbmt.2016.09.002. View